Related Experiment Videos
Marfan syndrome: no evidence for heterogeneity in different populations, and more precise mapping of the gene
K Kainulainen1, B Steinmann, F Collins
1Laboratory of Molecular Genetics, National Public Health Institute, Helsinki, Finland.
Abstract:
Marfan syndrome is a dominantly inherited connective tissue disorder with manifestations in the cardiovascular, ocular, and skeletal systems. The diagnosis is hampered by both high variability in the phenotypic expression and late manifestation of symptoms. The cause of Marfan syndrome remains unknown, but our group has recently reported the genetic linkage of Marfan syndrome to a polymorphic marker on chromosome 15. To analyze the possible heterogeneity behind Marfan syndrome, we have performed linkage analyses for four chromosome 15 markers in 17 families from five different populations: Scottish, English, Swiss, American, and Finnish. By combining the linkage data of all the studied families into a LINKMAP analysis we obtained a maximal LOD score of 11.2, which maps the Marfan syndrome locus between D15S25 and D15S45 on the long arm of chromosome 15. The data reveal no evidence for genetic heterogeneity behind Marfan syndrome and provide us with a more precise location of both the Marfan syndrome locus and flanking markers. This information will provide the basis for the DNA diagnostics of Marfan syndrome in the future.
Insights
Researchers mapped the Marfan syndrome locus to chromosome 15, excluding genetic heterogeneity. This precise location advances DNA diagnostics for this inherited connective tissue disorder.
Area of Science:
- Genetics
- Molecular Biology
- Medical Genetics
Background:
- Marfan syndrome is a dominantly inherited connective tissue disorder affecting cardiovascular, ocular, and skeletal systems.
- Diagnosis is challenging due to variable and late-onset symptoms.
- Previous research linked Marfan syndrome to chromosome 15.
Purpose of the Study:
- To investigate potential genetic heterogeneity in Marfan syndrome.
- To refine the location of the Marfan syndrome gene locus.
- To establish a basis for future DNA diagnostics.
Main Methods:
- Linkage analysis of four chromosome 15 markers in 17 families across five populations (Scottish, English, Swiss, American, Finnish).
- Utilized LINKMAP analysis to combine linkage data.
- Evaluated genetic heterogeneity of Marfan syndrome.
Main Results:
- Maximal LOD score of 11.2 obtained, mapping the Marfan syndrome locus between D15S25 and D15S45 on chromosome 15q.
- No evidence of genetic heterogeneity was found.
- Precise localization of the Marfan syndrome locus and flanking markers achieved.
Conclusions:
- Marfan syndrome locus is confirmed on chromosome 15, with no significant genetic heterogeneity.
- The identified locus and flanking markers provide a foundation for developing DNA-based diagnostic tests.
- This research significantly advances the genetic understanding and diagnostic capabilities for Marfan syndrome.